Testing a lab-made antibody for rabies prevention in healthy adults
Treatments studied
Part of Infections clinical trials.
This trial tests a new rabies-prevention medicine made in a lab. It is for healthy people, not those who have been bitten, and aims to see if the injection is safe and how the body handles it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between 18 and 60 years old.
- Your weight must be within certain limits (women: 45–80 kg, men: 50–80 kg) and your body mass index (BMI) must be between 18 and 26.
- You cannot have ever had a rabies vaccine or been exposed to a potentially rabid animal.
- You must not have significant health issues like autoimmune diseases, hepatitis, or epilepsy.
- You must be willing to avoid pregnancy or sperm donation and use effective birth control during the study.
- You must avoid smoking, heavy drinking, and strenuous exercise during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether different batches of a rabies vaccine produce the same immune response. You would receive the vaccine and have blood tests to check your antibody levels, helping ensure the vaccine works consistently.
This study tests a new rabies vaccine given after a possible exposure to rabies (like a bite) to see how well it works and how safe it is. The vaccine is given in a series of shots to help your body fight the rabies virus.
This study tests whether a single booster dose of the rabies vaccine is still effective in people who received the primary pre-exposure series several years ago. It compares three different vaccine regimens to see which one boosts immunity best.
This trial tests a new medicine made from antibodies that target tetanus toxin. It may help protect people from tetanus without needing a vaccine.
This study tests whether a new experimental rabies vaccine, when given with the standard rabies vaccine, is safe and helps the body build a strong immune response. It aims to find a better way to protect against rabies.
This trial tests a new lyophilized rabies vaccine to see how well it works and how safe it is. It is for people who have not been vaccinated against rabies recently and have not been bitten or scratched by an animal that broke the skin in the past year.
Hear when a new Rabies (Healthy Volunteers) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.